ORMP

Oramed Pharmaceuticals News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 3.67 0.00 0.00 0.00 3.67 08:58:04
more quote information »

Recent News

Date Time Source Heading
7/15/202009:17EDGARCurrent Report Filing (8-k)
7/15/202008:55PRNUSOramed Reports Positive End of Phase 2 Meeting With the FDA..
7/07/202016:14EDGARQuarterly Report (10-q)
6/30/202016:10EDGARProxy Statement (definitive) (def 14a)
6/16/202016:28EDGARProxy Statement - Notice of Shareholders Meeting..
6/15/202008:25PRNUSOramed Announces Positive Initial Clinical Trial Results for..
5/05/202007:55PRNUSOramed Pharmaceuticals to Present at the 80th American..
5/01/202011:17EDGARConfidential Treatment Order (ct Order)
5/01/202011:15EDGARConfidential Treatment Order (ct Order)
4/09/202016:43EDGARCurrent Report Filing (8-k)
4/07/202007:40PRNUSOramed Patent in Canada Allowed for Oral Delivery of..
4/06/202016:47EDGARQuarterly Report (10-q)
4/01/202008:40PRNUSOramed Pharmaceuticals Issues CEO Shareholder Letter..
3/19/202008:40PRNUSOramed Receives Positive Feedback From End-of-Phase 2 Oral..
3/02/202011:45EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/28/202013:11EDGARCurrent Report Filing (8-k)
2/27/202009:15PRNUSOramed Pharmaceuticals Inc. Prices Public Offering of Common..
2/26/202016:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/26/202016:05PRNUSOramed Pharmaceuticals Inc. Announces Proposed Public..
2/26/202008:04EDGARCurrent Report Filing (8-k)
2/26/202008:00PRNUSOramed Reports Positive Results in the Final Cohort of Its..
2/14/202011:56EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202011:47EDGARStatement of Ownership (sc 13g)
2/11/202006:01EDGARNotice of Effectiveness (effect)
2/10/202017:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/04/202008:25PRNUSOramed to Present at BIO CEO & Investor Conference
1/31/202016:09EDGARSecurities Registration Statement (simplified Form) (s-3)
1/30/202007:25PRNUSOramed Appoints Dr. Julio Rosenstock to Its Scientific..
1/28/202007:25PRNUSOramed Patent in Europe to be Granted for Oral Delivery of..
1/23/202008:00PRNUSOramed Elects Dr. Alexander Fleming to Scientific Advisory..
1/21/202014:41EDGARAmended Statement of Ownership (sc 13g/a)
1/21/202007:25PRNUSOramed Appoints Dr. Jay Skyler to Scientific Advisory Board
1/09/202015:58EDGARQuarterly Report (10-q)
1/09/202007:00PRNUSOramed Pharmaceuticals Issues Letter to Shareholders
12/11/201916:53EDGARInitial Statement of Beneficial Ownership (3)
12/06/201906:02EDGARCurrent Report Filing (8-k)
12/05/201909:12PRNUSOramed Appoints Dr. Arie Mayer to Board of Directors
12/02/201908:25PRNUSOramed to Present a Scientific Poster at International..
11/27/201916:28EDGARAnnual Report (10-k)
11/21/201908:27PRNUSOramed Patent Granted in Japan for Protease Inhibitor, a Key..
11/19/201908:55PRNUSOramed Provides Highlights and Data From Its Phase IIb Oral..
11/14/201907:28PRNUSOramed Pharmaceuticals to Discuss Positive Phase IIb Data at..
11/12/201907:04EDGARCurrent Report Filing (8-k)
11/12/201907:00PRNUSOramed Announces Successful Phase IIb Study of Oral Insulin..
10/23/201916:36EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/18/201908:38PRNUSOramed to Present at Ladenburg Thalmann 2019 Healthcare..
9/17/201908:40PRNUSOramed Announces Last Patient Treated in Pivotal Phase IIb..
9/16/201918:09EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:08EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201918:07EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NASDAQ
ORMP
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200803 13:16:09